Concepedia

Rachael B. Rowswell-Turner

RB

Statistics

Publications

11

Citations

388

H-Index

11

Active since

2009

Affiliations

University of Rochester Medical Center(Current)

Brown University

Rhode Island Hospital

Providence College

University at Buffalo, State University of New York

Rachael B. Rowswell-Turner is an author at University of Rochester Medical Center specializing in oncology, immunology, and cancer immunology.

ORCID

Publications per year

2009–2024

11

Publications

11

AI is a viable alternative to high throughput screening: a 318-target study

Izhar Wallach, Denzil Bernard, Kong T. Nguyen et al. · Scientific Reports · 2024 · 120 citations · Full text

, , +16

Central Role of IFNγ–Indoleamine 2,3-Dioxygenase Axis in Regulation of Interleukin-12–Mediated Antitumor Immunity

Tao Gu, Rachael B. Rowswell-Turner, Mehmet O. Kilinc et al. · Cancer Research · 2009 · 61 citations

, , +17

Activated CD8+ T-Effector/Memory Cells Eliminate CD4+ CD25+ Foxp3+ T-Suppressor Cells from Tumors via FasL Mediated Apoptosis

Mehmet O. Kilinc, Rachael B. Rowswell-Turner, Tao Gu et al. · The Journal of Immunology · 2009 · 38 citations · Full text

, , +17

The biomarker HE4 (WFDC2) promotes a pro-angiogenic and immunosuppressive tumor microenvironment via regulation of STAT3 target genes

Nicole E. James, Jenna Emerson, Ashley Borgstadt et al. · Scientific Reports · 2020 · 37 citations · Full text

, , +17

HE4 Overexpression by Ovarian Cancer Promotes a Suppressive Tumor Immune Microenvironment and Enhanced Tumor and Macrophage PD-L1 Expression

Rachael B. Rowswell-Turner, Rakesh K. Singh, Anze Urh et al. · The Journal of Immunology · 2021 · 32 citations

, , +17

1–5 of 11